Literature DB >> 23483189

Mechanisms of RAS/β-catenin interactions.

Eva Zeller1, Katharina Hammer, Melissa Kirschnick, Albert Braeuning.   

Abstract

Signaling through the WNT/β-catenin and the RAS (rat sarcoma)/MAPK (mitogen-activated protein kinase) pathways plays a key role in the regulation of various physiological cellular processes including proliferation, differentiation, and cell death. Aberrant mutational activation of these signaling pathways is closely linked to the development of cancer in many organs, in humans as well as in laboratory animals. Over the past years, more and more evidence for a close linkage of the two oncogenic signaling cascades has accumulated. Using different experimental approaches, model systems, and experimental conditions, a variety of molecular mechanisms have been identified by which signal transduction through WNT/β-catenin and RAS interact, either in a synergistic or an antagonistic manner. Mechanisms of interaction comprise an upstream crosstalk at the level of pathway-activating ligands and their receptors, interrelations of cytosolic kinases involved in either pathways, as well as interaction in the nucleus related to the joint regulation of target gene transcription. Here, we present a comprehensive review of the current knowledge on the interaction of RAS/MAPK- and WNT/β-catenin-driven signal transduction in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483189     DOI: 10.1007/s00204-013-1035-3

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

Review 1.  Role of retinoids in the prevention and treatment of colorectal cancer.

Authors:  Catherine C Applegate; Michelle A Lane
Journal:  World J Gastrointest Oncol       Date:  2015-10-15

Review 2.  Liver zonation: Novel aspects of its regulation and its impact on homeostasis.

Authors:  Rolf Gebhardt; Madlen Matz-Soja
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  β-Catenin-RAS interaction serves as a molecular switch for RAS degradation via GSK3β.

Authors:  Sang-Kyu Lee; Woo-Jeong Jeong; Yong-Hee Cho; Pu-Hyeon Cha; Jeong-Su Yoon; Eun Ji Ro; Sooho Choi; Jeong-Min Oh; Yunseok Heo; Hyuntae Kim; Do Sik Min; Gyoonhee Han; Weontae Lee; Kang-Yell Choi
Journal:  EMBO Rep       Date:  2018-11-09       Impact factor: 8.807

4.  Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.

Authors:  Ramesh C Kovi; Sachin Bhusari; Deepak Mav; Ruchir R Shah; Thai Vu Ton; Mark J Hoenerhoff; Robert C Sills; Arun R Pandiri
Journal:  Arch Toxicol       Date:  2019-07-05       Impact factor: 5.153

5.  P2Y2 purinergic receptor activation is essential for efficient hepatocyte proliferation in response to partial hepatectomy.

Authors:  Bryan C Tackett; Hongdan Sun; Yu Mei; Janielle P Maynard; Sayuri Cheruvu; Arunmani Mani; Andres Hernandez-Garcia; Nadarajah Vigneswaran; Saul J Karpen; Sundararajah Thevananther
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-09       Impact factor: 4.052

6.  Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).

Authors:  Ahmet M Ulusan; Praveen Rajendran; Wan Mohaiza Dashwood; Omer F Yavuz; Sabeeta Kapoor; Trace A Gustafson; Michelle I Savage; Powel H Brown; Shizuko Sei; Altaf Mohammed; Eduardo Vilar; Roderick H Dashwood
Journal:  Cancer Prev Res (Phila)       Date:  2020-12-04

7.  ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1.

Authors:  Yihua Wang; Fangfang Bu; Christophe Royer; Sébastien Serres; James R Larkin; Manuel Sarmiento Soto; Nicola R Sibson; Victoria Salter; Florian Fritzsche; Casmir Turnquist; Sofia Koch; Jaroslav Zak; Shan Zhong; Guobin Wu; Anmin Liang; Patricia A Olofsen; Holger Moch; David C Hancock; Julian Downward; Robert D Goldin; Jian Zhao; Xin Tong; Yajun Guo; Xin Lu
Journal:  Nat Cell Biol       Date:  2014-10-26       Impact factor: 28.824

8.  The Canonical Wnt Pathway Drives Macropinocytosis in Cancer.

Authors:  Gil Redelman-Sidi; Anna Binyamin; Isabella Gaeta; Wilhelm Palm; Craig B Thompson; Paul B Romesser; Scott W Lowe; Mukta Bagul; John G Doench; David E Root; Michael S Glickman
Journal:  Cancer Res       Date:  2018-06-05       Impact factor: 13.312

9.  Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.

Authors:  E Lemieux; S Cagnol; K Beaudry; J Carrier; N Rivard
Journal:  Oncogene       Date:  2014-12-15       Impact factor: 9.867

10.  E-cadherin and K-ras: implications of a newly developed model of gastric cancer.

Authors:  Jacob E Till; Sam S Yoon; Sandra Ryeom
Journal:  Oncoscience       Date:  2017-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.